TCTR20210707010已完成2 期
Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT
Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital0 个研究点目标入组 14 人开始时间: 2021年7月7日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. critically ill ALF or ACLF adult patients with AKI, 2. aged more than 18 y old, 3. receiving CRRT
排除标准
- •1. severe acidosis (pH < 7.1) or severe alkalosis (pH > 7.55), 2. blood transfusion within 24 h prior to the study, 3. use of citrate-containing medications, 4. severe hypocalcemia (serum ionized calcium < 0.8 mmol/L), 5. use of heparin as anticoagulation.
研究者
相似试验
已完成
不适用
Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRTCitrate ToxicityRegional Citrate AnticoagulationLiver Failure, AcuteLiver Failure, Acute on ChronicPharmacokineticContinuous Renal Replacement TherapyNCT04959110Chulalongkorn University20
尚未招募
不适用
A prospective study conducted in an adult intensive care unit to measure the breakdown products of citrate during kidney dialysisACTRN12619000590167Sunshine Coast University Hospital20
Unknown
不适用
Citrate Pharmacokinetics and Regional Citrate Anticoagulation in CRRTAcute Kidney Failure With or Without:SepsisHepatic InsufficiencyMODSNCT00948558Huashan Hospital40
已完成
1 期
Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy SubjectsHepatic InsufficiencyNCT02183376Boehringer Ingelheim33
已完成
不适用
Pharmacokinetics of Ciprofloxacin in Critically Ill PatientsBacterial InfectionsNCT03016845Radboud University Medical Center40